Anders B Christensen

Dr. Anders B. Christensen studied Immunology and biotechnology at the University of Southern Denmark and took a PhD in plant pathology and Biotechnology from Copenhagen University (Agricultural University) in 1997. In 2000 he joined Novo Nordisk pharma as a development scientist and worked as a principal scientist at CMC Biologics from 2011. From 2008 to 2011 and from 2015 to present he was first with Klifo A/S and then with BioCMC as Pharma/CMC consultant. He cofounded Apillet ApS in 2018 where he is now the CEO.